Participated · Series A · Jul 2026

Balance Theory offers an AI-native platform that brings the cybersecurity investment lifecycle together through a system of record, a system of intelligence, and a system of execution. The platform is designed to help CISOs understand their enterprise, navigate the market, and move investment decisions into execution with confidence. The company reports it manages more than $1 billion in security investment spend and that customers see an average first-year ROI exceeding 300%. Cybersecurity veteran Dan Burns joined the company as executive chairman as it scales. Balance Theory is using recent funding to accelerate go-to-market efforts, deepen enterprise integrations, expand its market intelligence, and continue building agents and skills within the product. Its positioning targets the challenges security leaders face in prioritizing investments and translating strategy into measurable action.

Led · Seed · Jul 2026

Stemora Inc., based in Frederick, Md., is developing regenerative, stem cell–based approaches that target cartilage degeneration to halt and potentially reverse osteoarthritis. The company aims to deliver lasting structural restoration and functional recovery by addressing the root cause of the disease. In 2025 Stemora received funding from the Maryland Stem Cell Research Fund’s Commercialization Fund and in 2026 secured a $25,000 investment from TEDCO’s RBII program to continue R&D. Stemora’s public statements emphasize advancing research to stop and reverse cartilage degeneration and improve patients’ quality of life. The announcement did not disclose revenue, users, or other operating metrics.

Led · Seed · Jul 2026

BC3 Technologies, founded in Baltimore and led by CEO Wayne Grube, Jr., develops medical technologies aimed at improving emergency preparedness, emergency medical response, and hemorrhage control. The company says its work is intended to bridge the gap between injury and professional medical care. BC3's stated mission is to make lifesaving technology more accessible to first responders, workplaces, families, the military and communities. Following the TEDCO Pre-Seed Builder Fund investment, BC3 plans to use proceeds to support growth and to enhance research and product development. The announcement did not disclose revenue, users, or other financial metrics.

Led · Seed · Jul 2026

Irazú Oncology is developing cancer immunotherapies using an Outer Membrane Vesicle (OMV) platform that employs non-replicating, self-adjuvanted, bacteria-derived engineered nanoparticles to display and deliver tumor antigens for antigen presentation. The platform is designed to deliver multiple tumor targets in a single therapy and to generate durable anti-tumor responses. The company is located in the University of Maryland BioPark in Baltimore, Md., and is led by CEO Jeff Strovel. Irazú has participated in TEDCO programs, receiving a Maryland Innovation Initiative Company Formation Award in 2023 and prior Seed Funds support in 2025, and has engaged with TEDCO’s FLLIP Pilot Program and Loaned Executive mentorship. The company states the recent funding will help advance its program toward clinical development. No revenues, user counts, or other operating metrics were disclosed in the announcement.

Led · Equity · Jun 2026

ION Storage Systems is developing a solid-state battery platform built around a patented solid-state anode technology. The company targets multiple markets including defense and aerospace, medical, consumer electronics, electric vehicles, and grid storage. ION has announced cell performance qualification as part of its commercialization progress. The June 2026 press release states the company is located in Beltsville, Md. ION positions its anode technology as offering a step change in performance while being easy to integrate to lower risk for EV applications. The company received a $2 million investment from TEDCO’s Venture Funds to support continued commercialization activities.